The source document for this Digest states:
Often the weakest link in determining whether observed adverse effects in humans and/or wildlife are linked to EDCs is the absence of adequate exposure data. Often data are limited to accidentally highly exposed groups. Most exposure information has focused on the presence of persistent organic pollutants in Europe and North America. Data on the magnitude and trends of global human or wildlife exposure are limited. Potential sources of exposure are through contaminated food, contaminated groundwater, combustion sources, and contaminants in consumer products. Information on exposure during critical development periods is generally lacking. The exposure data sets that exist are primarily for various environmental media (air, food, water) rather than the most relevant internal exposure (blood, tissue). Limited exceptions are human breast milk and adipose tissue samples. Worldwide, despite large expenditures of money, time, and effort, comparable data sets for assessing exposures to EDCs for humans or wildlife are not available. Such information is essential to adequately evaluate exposure–response relationships in field and epidemiological studies and to use these relationships to produce credible risk assessments.
Source & ©:
IPCS"Global Assessment of the state-of-the-science of
Endocrine disruptors
For details on: | See IPCS assessment: |
Exposure issues for EDCs |
2.5, page 8 |
The kind of exposure studies that are needed on EDCs |
6.1, page 89 |
For details on: | See IPCS assessment: |
Sources of exposure to EDCs |
6.2.1, page 90 |
Pathways of exposure to EDCs via air, water, soil, sediment, food and consumer products |
6.2.2, page 91 |
Exposure via air to volatile compounds such as lindane, nonhalogenated aromatic hydrocarbons, phenols and phthalate esters |
6.2.2.1, page 91 |
Exposure via water to water-soluble compounds such as pesticides, industrial chemicals and natural hormones |
6.2.2.2, page 91 |
Exposure via soil and sewage sludge to compounds such as PCBs, dioxins and PBDEs |
6.2.2.3, page 91 |
Exposure of wildlife via sediments |
6.2.2.4, page 91 |
Exposure via food, the major exposure route for humans and wildlife |
6.2.2.5, page 91 |
Exposure via consumer products such as exposure to phthalate esters in young children chewing on toys and teething rings |
6.2.2.6, page 92 |
For details on: | See IPCS assessment: |
The difference between intake and uptake of environmental chemicals with EDC potential |
6.2.3, page 92 |
The internal dose and pharmacokinetics of EDCs |
6.2.4, page 92 |
For details on: | See IPCS assessment: |
Exposure to persistent organic pollutants in the Baltic sea, Great Lakes region and Arctic region |
6.3.1.1, page 93 |
Global distribution of DDT and PCBs in marine mammals |
6.3.1.1.4, page 95 |
The impact of TBT, used in antifouling paints applied to hulls of ships, on coastal areas |
6.3.1.2, page 96 |
The source and fate of alkyl phenols (APs), alkylphenol ethoxylates (APEs) and their degradation products |
6.3.1.3, page 96 |
Summary and conclusions on wildlife EDC exposures |
6.3.1.4, page 98 |
For details on: | See IPCS assessment: |
Dioxins ingested through food and decreasing levels in breast milk |
6.3.2.1, page 98 |
PCB exposure due persistence in the environment and continued use in some parts of the world |
6.3.2.3, page 100 |
PBDEs that are present in food and may be released from television sets and computers, and are found in increasing amounts in human breast milk |
6.3.2.3, page 100 |
DDT that is still used in some developing countries |
6.3.2.4, page 100 |
Phthalates that are present in various types of plastics |
6.3.2.5, page 100 |
Atrazine that may be present in groundwater and drinking water |
6.3.2.6, page 100 |
Phytoestrogens that are naturally present in foods such as soy |
6.3.2.7, page 100 |
Conclusions on human EDC exposures |
6.3.2.8, page 101 |
For details on: | See IPCS assessment: |
Ways of measuring EDC exposure |
6.4, page 101 |
Key issues involved in sampling to measure EDC exposure |
6.4.1, page 102 |
Multi-residue methods that can test for a broad range of chemicals in a single sample used for screening purposes |
6.4.2.1, page 102 |
Using combined chemical and biological methods to identify EDCs in environmental samples |
6.4.2.2, page 102 |
Biological methods currently available for detecting hormonally active substances |
6.4.2.2.1, page 102 |
The toxic identification evaluation (TIE) approach that uses in vitro bioassays in conjunction with chemical methods for identifying EDCs |
6.4.2.2.2, page 103 |
For details on: | See IPCS assessment: |
Potential endocrine disruptors that exist as mixtures of related chemicals (isomers and congeners) |
6.4.3, page 103 |
PCB congeners and other EDCs that exist as mirror images (chiral pairs) |
6.4.3.1, page 103. |
The various systems for weighting the amounts of individual congeners in a mixture in proportion to their toxicity |
6.4.3.2, page 103 |
The importance of quality assurance and quality control (QA/QC) procedures to ensure EDC measurements from around the world are comparable |
6.4.4, page 104 |
Exposure models that can be used when measurements are limited |
6.4.4, page 104 |
Structure-activity methods that can be used to estimate the potential EDC activity of untested chemicals |
6.4.5, page 104 |
Summary and conclusions on EDC exposure issues in wildlife and humans |
6.5, page 105 |
This summary is free and ad-free, as is all of our content. You can help us remain free and independant as well as to develop new ways to communicate science by becoming a Patron!